论文部分内容阅读
目的研究对接受抗血管生成治疗(索拉非尼)和抗表皮生长因子(埃罗替尼)治疗的晚期/转移非小细胞肺癌病人,进行系列动态增强CT检查的可行性,并对肿瘤血流量
Objective To investigate the feasibility of series dynamic contrast-enhanced CT in patients with advanced / metastatic non-small cell lung cancer treated with anti-angiogenic therapy (sorafenib) and anti-epidermal growth factor (erlotinib) flow